Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.89
-0.04 (-0.58%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Bausch Health Companies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,098157-46-592-225-948
Depreciation & Amortization
1,1721,2081,2671,2641,3941,552
Other Amortization
739455659955
Loss (Gain) From Sale of Assets
-9-6-10-3-586
Asset Writedown & Restructuring Costs
1,58815329547839615
Stock-Based Compensation
233216150132126128
Provision & Write-off of Bad Debts
807162565160
Other Operating Activities
32-27483145-2,6116
Change in Accounts Receivable
-75-134-216-195-57-229
Change in Inventory
-25-12-267-322-198-16
Change in Accounts Payable
-217-76357158-75121
Change in Other Net Operating Assets
463133-223-66-4
Operating Cash Flow
1,8001,4001,5971,032-7281,426
Operating Cash Flow Growth
19.52%-12.34%54.75%--28.35%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-369-397-337-215-218-269
Sale of Property, Plant & Equipment
107755669
Cash Acquisitions
-207-204-136-1,890-45-
Sale (Purchase) of Intangibles
-38-10-3-57-50-14
Investment in Securities
-4-32-15-4
Other Investing Activities
11121313-27
Investing Cash Flow
-597-595-454-2,145-303409

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-10,5546613,2916,8362,100
Total Debt Issued
3,01810,5546613,2916,8362,100
Long-Term Debt Repaid
--11,191-1,460-1,710-7,846-3,440
Total Debt Repaid
-4,025-11,191-1,460-1,710-7,846-3,440
Net Debt Issued (Repaid)
-1,007-637-7991,581-1,010-1,340
Repurchase of Common Stock
-47-24-26-24-31-52
Other Financing Activities
-49-81-43-82567-121
Financing Cash Flow
-1,103-742-8681,475-474-1,513

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-561-369-23-19
Net Cash Flow
95124239371-1,528303

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4311,0031,260817-9461,157
Free Cash Flow Growth
28.34%-20.40%54.22%--43.02%
Free Cash Flow Margin
13.18%9.77%13.09%9.33%-11.64%13.72%
Free Cash Flow Per Share
3.842.673.422.24-2.613.22
Levered Free Cash Flow
1,4341,0871,721738.131,0171,627
Unlevered Free Cash Flow
2,3651,9952,5331,5031,8332,464

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,8101,8101,6741,5331,5401,419
Cash Income Tax Paid
16316361237266240
Change in Working Capital
-271-2197-582-396-128
SEC Filings: 10-K · 10-Q